Changes in Matrix Metalloproteinase 2 Activities in Amniochorions During Premature Rupture of Membranes

Journal of the Society for Gynecologic Investigation

Volumn 13, Issue 8, 2006, Pages 592-597

  Ota, Atsuyuki ^a   Yonemoto, Hisashi ^a   Someya, Akimasa ^a   Itoh, Shigeru ^a   Kinoshita, Katsuyuki ^a   Nagaoka, Isao ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Matrix metalloproteinase; MMP 2; MT1 MMP; PROM; TIMP 1

Indexed keywords

GELATINASE A; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

AMNION CELL; ARTICLE; CESAREAN SECTION; CHORION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SPECIFICITY; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; FEMALE; FETUS MEMBRANE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPECTROPHOTOMETRY; TISSUE SECTION; VAGINAL DELIVERY; WESTERN BLOTTING;

AMNION; CHORION; ENZYME PRECURSORS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; MATRIX METALLOPROTEINASE 2; PREGNANCY; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 33845441441     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsgi.2006.10.001     Document Type: Article

References (38)

1. Rajabi M.R., Dean D.D., Beydoun S.N., and Woessner Jr. J.F. Elevated tissue levels of collagenase during dilation of uterine cervix in human parturition. Am J Obstet Gynecol 159 (1988) 971-976
2. Bryant-Greenwood G.D., and Yamamoto S.Y. Control of peripartal collagenolysis in the human chorion-decidua. Am J Obstet Gynecol 172 (1995) 63-70
3. Tsatas D., Baker M.S., and Rice G.E. Differential expression of proteases in human gestational tissues before, during and after spontaneous-onset labour at term. J Reprod Fertil 116 (1999) 43-49
4. Draper D., McGregor J., Hall J., et al. Elevated protease activities in human amnion and chorion correlate with preterm premature rupture of membranes. Am J Obstet Gynecol 173 (1995) 1506-1512
5. Fortunato S.J., and Menon R. Screening of novel matrix metalloproteinases (MMPs) in human fetal membranes. J Assist Reprod Genet 19 (2002) 483-486
6. Vadillo-Ortega F., and Estrada-Gutierrez G. Role of matrix metalloproteinases in preterm labour. BJOG 112 Suppl 1 (2005) 19-22
7. Fernandez P.L., Merino M.J., Nogales F.F., Charonis A.S., Stetler-Stevenson W., and Liotta L. Immunohistochemical profile of basement membrane proteins and 72 kilodalton type IV collagenase in the implantation placental site. An integrated view. Lab Invest 66 (1992) 572-579
8. Salo T., Liotta L.A., and Tryggvason K. Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells. J Biol Chem 258 (1983) 3058-3063
9. Fortunato S.J., Menon R., and Lombardi S.J. Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic membrane. Am J Obstet Gynecol 177 (1997) 731-741
10. Locksmith G.J., Clark P., Duff P., Saade G.R., and Schultz G.S. Amniotic fluid concentrations of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during pregnancy and labor. Am J Obstet Gynecol 184 (2001) 159-164
11. Maymon E., Romero R., Pacora P., et al. A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intraamniotic infection. J Perinat Med 29 (2001) 308-316
12. Xu P., Alfaidy N., and Challis J.R. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab 87 (2002) 1353-1361
13. Vadillo-Ortega F., Hernandez A., Gonzalez-Avila G., Bermejo L., Iwata K., and Strauss III J.F. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 174 (1996) 1371-1376
14. Athayde N., Edwin S.S., Romero R., et al. A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol 179 (1998) 1248-1253
15. Roth I., and Fisher S.J. IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev Biol 205 (1999) 194-204
16. Peled Z.M., Phelps E.D., Updike D.L., et al. Matrix metalloproteinases and the ontogeny of scarless repair: The other side of the wound healing balance. Plast Reconstr Surg 110 (2002) 801-811
17. Nakada M., Yamada A., Takino T., et al. Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes. Cancer Res 61 (2001) 8896-8902
18. Maymon E., Romero R., Pacora P., et al. Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection. Am J Obstet Gynecol 183 (2000) 887-894
19. Goto T., Endo T., Henmi H., et al. Gonadotropin-releasing hormone agonist has the ability to induce increased matrix metalloproteinase (MMP)-2 and membrane type 1-MMP expression in corpora lutea, and structural luteolysis in rats. J Endocrinol 161 (1999) 393-402
20. Kinoh H., Sato H., Tsunezuka Y., et al. MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis. J Cell Sci 109 (1996) 953-959
21. Hulboy D.L., Rudolph L.A., and Matrisian L.M. Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod 3 (1997) 27-45
22. Fortunato S.J., Menon R., and Lombardi S.J. Expression of a progelatinase activator (MT1-MMP) in human fetal membranes. Am J Reprod Immunol 39 (1998) 316-322
23. Vadillo-Ortega F., Gonzalez-Avila G., Furth E.E., et al. 92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am J Pathol 146 (1995) 148-156
24. Ulug U., Goldman S., Ben-Shlomo I., and Shalev E. Matrix metalloproteinase (MMP)-2 and MMP-9 and their inhibitor, TIMP-1, in human term decidua and fetal membranes: The effect of prostaglandin F(2alpha) and indomethacin. Mol Hum Reprod 7 (2001) 1187-1193
25. Goldman S., Weiss A., Eyali V., and Shalev E. Differential activity of the gelatinases (matrix metalloproteinases 2 and 9) in the fetal membranes and decidua, associated with labour. Mol Hum Reprod 9 (2003) 367-373
26. Yonemoto H., Young C.B., Ross J.T., Guilbert L.L., Fairclough R.J., and Olson D.M. Changes in matrix metalloproteinase (MMP)-2 and MMP-9 in the fetal amnion and chorion during gestation and at term and preterm labor. Placenta 27 (2006) 669-677
27. Fortunato S.J., Menon R., and Lombardi S.J. Presence of four tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, -3 and -4) in human fetal membranes. Am J Reprod Immunol 40 (1998) 395-400
28. Emonard H., Bellon G., Troeberg L., et al. Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2.TIMP-2 complex through a thrombospondin-independent mechanism. J Biol Chem 279 (2004) 54944-54951
29. Riley S.C., Leask R., Denison F.C., Wisely K., Calder A.A., and Howe D.C. Secretion of tissue inhibitors of matrix metalloproteinases by human fetal membranes, decidua and placenta at parturition. J Endocrinol 162 (1999) 351-359
30. Park K.H., Chaiworapongsa T., Kim Y.M., et al. Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity. J Perinat Med 31 (2003) 12-22
31. Someya A., Nishijima K., Nunoi H., Irie S., and Nagaoka I. Study on the superoxide-producing enzyme of eosinophils and neutrophils-Comparison of the NADPH oxidase components. Arch Biochem Biophys 345 (1997) 207-213
32. Malak T.M., Ockleford C.D., Bell S.C., Dalgleish R., Bright N., and Macvicar J. Confocal immunofluorescence localization of collagen types I, III, IV, V and VI and their ultrastructural organization in term human fetal membranes. Placenta 14 (1993) 385-406
33. Vadillo-Ortega F., Gonzalez-Avila G., Karchmer S., Cruz N.M., Ayala-Ruiz A., and Lama M.S. Collagen metabolism in premature rupture of amniotic membranes. Obstet Gynecol 75 (1990) 84-88
34. Fortunato S.J., Menon R., and Lombardi S.J. MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture. J Perinat Med 27 (1999) 362-368
35. Fortunato S.J., Menon R., and Lombardi S.J. Amniochorion gelatinase-gelatinase inhibitor imbalance in vitro: A possible infectious pathway to rupture. Obstet Gynecol 95 (2000) 240-244
36. Fortunato S.J., and Menon R. Distinct molecular events suggest different pathways for preterm labor and premature rupture of membranes. Am J Obstet Gynecol 184 (2001) 1399-1405
37. Evaldson G.R., Larsson B., Jiborn H., and Nord C.E. Does an intracervical infection influence the fibrinolytic activity and the collagen content of the fetal membranes? A study of ascending infections in pregnant ewes. Eur J Obstet Gynecol Reprod Biol 25 (1987) 259-266
38. Moore R.M., Mansour J.M., Redline R.W., Mercer B.M., and Moore J.J. The physiology of fetal membrane rupture: insight gained from the determination of physical properties. Placenta 27 (2006) 1037-1051